×

걸음걸이 속도와 인지기능의 연관성
임상노인의학회지 9/4 :417-425,2008

걸음걸이 속도와 인지기능과의 연관성
대한임상노인학회지 9/4 :417-425,2008

복부초음파 수검자에서 담낭용종의 유병률
가정의학회지 30/1 :39-45,2009

Relationship Between Earlobe Crease and Brachial-ankle Pulse Wave Velocity in Non-hypertensive, Non-diabetic adults in korea.
Epidemiology and Health 31/6 :e2009002-e2009002,2009

Clinical Predictors of Novel Influenza A (H1N1) Infection in Korea
YONSEI MEDICAL JOURNAL 51/6 :895-900,2010

Extended-Spectrum β-Lactamase을 생성하는 Escherichia Coli 감염에 의한 패혈증 1예
Journal Of The Korean Academy Of Family Medicine 31/5 :384-389,2010

Is abdominal obesity associated with the 2009 influenza A (H1N1) pandemic in Korean school-aged children?
Influenza and Other Respiratory Viruses 6/ :313-317,2012

Influence of ABCC2, SLCO1B1, and ABCG2 polymorphisms on the pharmacokinetics of olmesartan
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY 60/1 :49-54,2012

Impact of ABCC2, ABCG2 and SLCO1B1 polymorphisms on the pharmacokinetics of pitavastatin in humans
DRUG METABOLISM AND PHARMACOKINETICS 28/3 :196-202,2013

Influence of Hepatic Dysfunction on the Pharmacokinetics and Safety of Fimasartan
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY 62/6 :524-529,2013

First-in-human study with new recombinant agalsidase beta (ISU303) in healthy subjects
JOURNAL OF CLINICAL PHARMACOLOGY 54/6 :675-681,2014

Effect of Ketoconazole on Lobeglitazone Pharmacokinetics in Korean Volunteers
CLINICAL THERAPEUTICS 36/7 :1064-1071,2014

Pharmacokinetic Interaction Between Amlodipine and Lobeglitazone, a Novel Peroxisome Proliferator-activated Receptor-gamma Agonist, in Healthy Subjects
CLINICAL THERAPEUTICS 37/9 :1999-2006,2015

Pharmacokinetics, pharmacodynamics and safety of CKD-519, a CETP inhibitor, in healthy subjects
DRUG DESIGN DEVELOPMENT AND THERAPY 10/ :3,763-3,770,2016

Effects of JOINS® on the pharmacokinetic profiles of aceclofenac in healthy Korean volunteers: an open-label, multiple-dose, one sequence, two-period study
Translational and Clinical Pharmacology(임상약리학회지) 24/4 :169-174,2016

Pharmacokinetic interactions between glimepiride and rosuvastatin in healthy Korean subjects: Does the SLCO1B1 or CYP2C9 genetic polymorphism affect these drug interactions?
DRUG DESIGN DEVELOPMENT AND THERAPY 11/ :503-512,2017

Decreased potency of fimasartan in liver cirrhosis was quantified using mixed-effects analysis
Translational and Clinical Pharmacology(임상약리학회지) 25/1 :43-51,2017

Comparison of Pharmacokinetics and Safety of a Fixed-dose Combination of Rosuvastatin and Ezetimibe Versus Separate Tablets in Healthy Subjects
CLINICAL THERAPEUTICS 39/9 :1,799-1,810,2017

A comparison of the pharmacokinetic and pharmacodynamic properties of nitroglycerin according to the composition of the administration set: A preliminary study
MEDICINE 97/9 :e9,829-e9,836,2018

Coagulant Effect and Tolerability of Yeast-Produced Recombinant Batroxobin in Healthy Adult Subjects
CLINICAL DRUG INVESTIGATION 38/9 :829-835,2018

Comparison of biosimilar filgrastim with a reference product: Pharmacokinetics, pharmacodynamics, and safety profiles in healthy volunteers
DRUG DESIGN DEVELOPMENT AND THERAPY 12/ :2,381-2,387,2018

Effects of Gelidium elegans on Weight and Fat Mass Reduction and Obesity Biomarkers in Overweight or Obese Adults: A Randomized Double-Blinded Study
NUTRIENTS 11/7 :E1513-,2019

The safety, pharmacodynamics, and pharmacokinetics of immediate-release formulation containing esomeprazole 20 mg/sodium bicarbonate 800 mg in healthy adult male
DRUG DESIGN DEVELOPMENT AND THERAPY 13/ :3,151-3,159,2019